Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'
Journal
Allergy
Date Issued
2024-03-03
Author(s)
Demidova, Anastasia
Drewitz, Karl Philipp
Kimkool, Parisut
Banjanin, Nikolina
Barzylovich, Vladyslava
Botjes, Erna
Capper, India
Castor, Mary Anne R
Comberiati, Pasquale
Cook, Emma E
Costa, Joana
Chu, Derek K
Epstein, Michelle M
Galvin, Audrey Dunn
Giovannini, Mattia
Girard, Frédéric
Golding, Michael A
Greenhawt, Matthew
Ierodiakonou, Despo
Jones, Christina J
Khaleva, Ekaterina
Knibb, Rebecca C
Macit-Çelebi, Melahat Sedanur
Mack, Douglas P
Mafra, Isabel
Marchisotto, Mary Jane
Nekliudov, Nikita
Özdemir, Cevdet
Patel, Nandinee
Pazukhina, Ekaterina
Protudjer, Jennifer L P
Rodríguez Del Rio, Pablo
Roomet, Jelena
Sammut, Patrick
Schoos, Ann-Marie Malby
Schopfer, Anita Fossaluzza
Schultz, Fallon
Seylanova, Nina
Skypala, Isabel
Sørensen, Martin
Stylianou, Eva
Upton, Julia
van de Veen, Willem
Genuneit, Jon
Boyle, Robert J
Apfelbacher, Christian
Munblit, Daniel
DOI
10.1111/all.16023
Abstract
IgE-mediated food allergy (FA) is a global health concern with substantial individual and societal implications. While diverse intervention strategies have been researched, inconsistencies in reported outcomes limit evaluations of FA treatments. To streamline evaluations and promote consistent reporting, the Core Outcome Measures for Food Allergy (COMFA) initiative aimed to establish a Core Outcome Set (COS) for FA clinical trials and observational studies of interventions.
File(s)![Thumbnail Image]()
Loading...
Name
Allergy - 2024 - Demidova - Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of.pdf
Size
2.53 MB
Format
Adobe PDF
Checksum
(MD5):285f44d3b5c36b304303aaa4c7f32928